Jonathan Gaik

Title: Innovator Spotlight: Jonathan Gaik

Introduction

Jonathan Gaik, a talented inventor based in Hazelwood, MO, has made significant contributions to the field of pharmaceuticals with his innovative designs and techniques. With a total of six patents to his name, Gaik continues to push the boundaries of pharmaceutical formulations, enhancing the safety and efficacy of medications.

Latest Patents

Gaik's latest inventions include groundbreaking technologies tailored for abuse deterrent applications in pharmaceuticals. One of his notable patents focuses on "Extended release, abuse deterrent dosage forms," which features crush-resistant controlled-release particles designed to provide abuse deterrent properties. These particles are formulated using a hot melt extrusion process and consist of plastic/elastic polymers blended with at least one active pharmaceutical ingredient (API) or a pharmaceutically acceptable salt.

Another significant patent involves "Abuse deterrent immediate release formulations comprising non-cellulose polysaccharides." This invention ensures immediate release of active ingredients while incorporating abuse deterrent properties. The pharmaceutical compositions include at least one active ingredient, non-cellulose polysaccharides, gelling polymers, and an effervescent system, which collectively enhance the safety profile of the medication.

Career Highlights

Jonathan Gaik is currently associated with Specgx LLC, where he leverages his expertise in pharmaceutical development to innovate and improve drug formulations. His patents reflect his dedication to addressing common concerns in the pharmaceutical industry, particularly the need for safer medication options.

Collaborations

Throughout his career, Gaik has collaborated with talented colleagues such as Jaehan Park and Ryan Lathrop. These partnerships have enabled the collaborative development and refinement of innovative pharmaceutical solutions, contributing to advancing safer medication practices.

Conclusion

Jonathan Gaik remains a prominent figure in the pharmaceutical innovation landscape. His patents not only represent his commitment to enhancing drug safety but also underscore the potential for meaningful contributions to public health. Through continued innovation at Specgx LLC, Gaik's work is poised to make a lasting impact in the industry.